Pharsight

Levitra patents expiration

LEVITRA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8841446 BAYER HLTHCARE Medicaments containing vardenafil hydrochloride trihydrate
Jul, 2023

(8 months ago)

US8273876 BAYER HLTHCARE Medicaments containing vardenafil hydrochloride trihydrate
Jul, 2027

(3 years from now)

Levitra is owned by Bayer Hlthcare.

Levitra contains Vardenafil Hydrochloride.

Levitra has a total of 2 drug patents out of which 1 drug patent has expired.

Expired drug patents of Levitra are:

  • US8841446

Levitra was authorised for market use on 19 August, 2003.

Levitra is available in tablet;oral dosage forms.

Levitra can be used as treatement of erectiile dysfunction by administering a film-coated tablet.

The generics of Levitra are possible to be released after 23 July, 2027.

Drugs and Companies using VARDENAFIL HYDROCHLORIDE ingredient

Market Authorisation Date: 19 August, 2003

Treatment: Treatement of erectiile dysfunction by administering a film-coated tablet

Dosage: TABLET;ORAL

How can I launch a generic of LEVITRA before it's drug patent expiration?
More Information on Dosage

LEVITRA family patents

Family Patents